Journals / Turkish Journal of Veterinary and Animal Sciences / 2020 / Cilt: 44 - Sayı: 5

Metabolic profile and adipokine levels in overweight and obese dogs

Pages
1093–1099
Publication Date
2022-11-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results have shown that obese dogs presented IR and alterations in fat metabolism.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Obesity in dogs is increasingly present in the veterinary practice.
📊
Key Findings & Data:In humans, it is known that there is a significant correlation between obesity and the development of hypertension and insulin resistance (IR), a clinical picture called metabolic syndrome.
💡
Conclusion & Impact:The results have shown that obese dogs presented IR and alterations in fat metabolism.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Obesity in dogs is increasingly present in the veterinary practice. In humans, it is known that there is a significant correlation between obesity and the development of hypertension and insulin resistance (IR), a clinical picture called metabolic syndrome. In dogs, however, there are only anecdotes about the syndrome. The objectives of this study were to determine serum levels of adiponectin, leptin, triglycerides, cholesterol, insulin, glucose, homeostasis assessment of B cell function (HOMA-B), homeostasis assessment of insulin resistance (HOMA-IR), and systolic blood pressure (SBP) in dogs with different body conditions (BC) and body fat (BF) without endocrine disease. For this purpose, 76 healthy dogs were submitted to evaluation of body conditions score (BCS) and morphometry. The dogs were separated into 3 groups: optimal BC [BCS 3,4, or 5 of 9 and BF% of 13 to 27-Group 1 (G1)], overweight [BCS 6 and 7 of 9 and BF% of 14 to 38- Group 2 (G2)], obese [BCS 8 and 9 of 9 and BF% greater than or equal to 34-Group 3 (G3)]. G3 presented higher serum levels of total protein, triglycerides, glucose, insulin, and HOMA-IR. Adipokines did not correlate to any other parameter, but the occurrence of hyperinsulinemia was higher in G3. The results have shown that obese dogs presented IR and alterations in fat metabolism.

🔖

Cite This Article

MARCHI, P. N. D., FAGNANI, R., MACHADO, L. H. D. A., HOLSBACK, L., CALESSO, J. R., JUNIOR, A. Z., CARDOSO, M. J. L. (2022). Metabolic profile and adipokine levels in overweight and obese dogs. Turkish Journal of Veterinary and Animal Sciences, Cilt: 44 - Sayı: 5, 1093–1099. https://ajindex.com/articles/614741

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Corbee RJ. Obesity in show dogs. Journal of Animal Physiology Animal Nutrition2013; 97 (5): 904-910. doi:10.1111/j.1439- 0396.2012.01336.x
  2. German AJ. The growing problem of obesity in dogs and cats. The Journal of Nutrition 2006; 136: 1940S-46S. doi: 10.1093/ jn/136.7.1940S
  3. Zoran DL. Obesity in dogs and cats: a metabolic and endocrine disorder. Veterinary Clinics of North America: Small Animal Practice2010; 40 (2): 221-239. doi: 10.1016/j.cvsm.2009.10.009
  4. Toth PP, Henriksson KM, Palmer MK. Metabolic syndrome and low-density lipoprotein cholesterol (LDL-C) goal attainment in the national health and nutrition examination survey (NHANES). In: National Lipid Association Scientific Sessions. New Orleans: Painel. 2016; 2003-12
  5. Park H, Lee S, Oh J, SEO K, Song K. Leptin, adiponectin and serotonin levels in lean and obese dogs. BMC Veterinary Research 2014; 10 (113): 1-8. doi: 10.1186/1746-6148-10-113
  6. Verkest KR, Rand JS, Fleeman LM, Morton JM, Richards AA, et al. Distinct adiponectin profiles might contribute to differences in susceptibility to type 2 diabetes in dogs and humans. Domestic Animal Endocrinology 2011a; 4: 67-73. doi: 10.1016/j.domaniend.2011.03.003
  7. Verkest KR, Fleeman LM, Morton JM, Ishioka K, Rand JS. Compensation for obesity-induced insulin resistance in dogs: assessment of the effects of leptin, adiponectin, and glucagon-like peptide-1 using path analysis. Domestic Animal Endocrinology 2011b; 41: 24-34. doi: 10.1016/j.domaniend.2011.02.001
  8. Tvarijonaviciute A, Cerón JJ, Holden SL, Cuthbertson DJ, Biourge V, et al. Obesity-related metabolic dysfunction in dogs: a comparison with human metabolic syndrome. BMC Veterinary Research 2012; 8 (147): 1-8. doi: 10.1186/1746- 6148-8-147
  9. Laflamme DP. Development and validation of a body condition score system for dogs. Canine Practice 1997; 22 (4): 10-15
  10. Burkholder WJ, Toll PW. Obesity. In: Hand MS, Tatcher CD, Remillard RL, Roudebusch. Small Animal Clinical Nutrition. 4th ed. Topeka: Mark Morris Institute; 2000; 401-430
  11. Behrend EN, Kooistra RN, Nelson CE, Reusch CE, Scott-Moncrieff JC. Diagnosis of spontaneous canine hyperadrenocorticism: 2012 ACVIM consensus statement (small animal). Journal of Veterinary Internal Medicine 2013; 27(6): 1292-304. doi: 10.1111/jvim.12192
  12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations